<p>Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin</p>
OncoTargets and Therapy2019Vol. Volume 12, pp. 1947–1956
Citations Over TimeTop 10% of 2019 papers
Abstract
Exosomal miR-21 derived from hypoxic NSCLC cells may promote cisplatin resistance, which indicates that exosomal miR-21 might be a potential biomarker and therapeutic target to address NSCLC chemoresistance.
Related Papers
- → Regulation of the PTEN phosphatase(2006)186 cited
- → Evaluation of phosphatase and tensin homologue (PTEN) expression in gastric cancer and its relationship with histopathological findings(2023)1 cited
- Expression of PTEN in non-small-cell lung carcinoma(2013)
- Regulatory mechanisms of PTEN(2009)